Form CORRESP - Correspondence:
SEC Accession No. 0001193125-23-252526
Filing Date
2023-10-06
Accepted
2023-10-06 21:42:55
Documents
5

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 15127
2 GRAPHIC g520772dsp1a.jpg GRAPHIC 7860
3 GRAPHIC g520772dsp1b.jpg GRAPHIC 6886
4 GRAPHIC g520772dsp2.jpg GRAPHIC 7741
5 GRAPHIC g520772footer.jpg GRAPHIC 16350
  Complete submission text file 0001193125-23-252526.txt   70243
Mailing Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453 6176515940
Aeglea BioTherapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations